| Not Yet Recruiting | Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic K NCT07405216 | Centenario Hospital Miguel Hidalgo | Phase 4 |
| Not Yet Recruiting | Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin NCT07175051 | University of Illinois at Chicago | Phase 2 |
| Enrolling By Invitation | Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Stu NCT06954090 | Steno Diabetes Center Copenhagen | Phase 4 |
| Recruiting | Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome NCT07173062 | Universidade do Porto | N/A |
| Not Yet Recruiting | Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose- NCT06147232 | Steno Diabetes Center Copenhagen | Phase 2 |
| Not Yet Recruiting | Clinical Findings and Albuminuria as Predictors of Acute Kidney Injury in Patients With Acute Heart Failure NCT06621862 | Hagar Mahmoud Hammad | — |
| Completed | Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinic NCT06094920 | University Medical Center Groningen | Phase 4 |
| Recruiting | Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa NCT05881447 | Swiss Tropical & Public Health Institute | — |
| Recruiting | Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116 | University of Colorado, Denver | Phase 4 |
| Completed | KidneYou - Innovative Digital Therapy NCT05286632 | Advice Pharma Group srl | N/A |
| Completed | SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes NCT04889183 | University Medical Center Groningen | Phase 3 |
| Terminated | TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension NCT05268926 | University Medical Center Groningen | Phase 2 |
| Completed | Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User NCT05838872 | Healthy.io Ltd. | N/A |
| Completed | Screening for Albuminuria at the First Line for Early Identification of CKD NCT05321095 | General Practitioners Research Institute | — |
| Recruiting | Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132 | Herlev Hospital | — |
| Recruiting | Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) NCT04752293 | Wake Forest University Health Sciences | — |
| Completed | Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. NCT06374043 | University Medical Center Groningen | Phase 4 |
| Terminated | Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria NCT03201939 | Vanderbilt University Medical Center | Phase 2 |
| Completed | Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands NCT04626271 | Healthy.io Ltd. | N/A |
| Completed | Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes NCT04635670 | Steno Diabetes Center Copenhagen | N/A |
| Unknown | Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches NCT04295889 | University Medical Center Groningen | N/A |
| Unknown | Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestina NCT04073927 | Steno Diabetes Center Copenhagen | N/A |
| Unknown | Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes M NCT04272359 | University of Milan | — |
| Unknown | Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes NCT03622957 | University of Pisa | — |
| Completed | Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria NCT03396328 | Yonsei University | N/A |
| Completed | Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. NCT03889236 | Leiden University Medical Center | N/A |
| Completed | Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit NCT03470701 | Geisinger Clinic | N/A |
| Completed | Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria NCT03118739 | AstraZeneca | Phase 2 |
| Completed | Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency NCT03667300 | Samsung Medical Center | Phase 2 |
| Completed | Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes NCT03015480 | Geisinger Clinic | N/A |
| Completed | Sodium Lowering and Urinary Protein Reduction Trial NCT02945969 | Tulane University School of Public Health and Tropical Medicine | Phase 3 |
| Completed | Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy NCT02689778 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 3 |
| Unknown | Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKD NCT02417571 | Seoul National University Hospital | N/A |
| Completed | Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease NCT02497300 | University of Alabama at Birmingham | Phase 2 |
| Completed | A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Di NCT01989754 | Janssen Research & Development, LLC | Phase 4 |
| Completed | Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23 NCT02020785 | Geisinger Clinic | N/A |
| Completed | Effect of NWT-03 on Blood Pressure NCT02144740 | Newtricious R&D BV | N/A |
| Completed | Influence of Aliskiren on Albuminuria After Kidney Transplantation NCT02446548 | Medical University of Gdansk | N/A |
| Completed | Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albumi NCT02376075 | ikfe-CRO GmbH | Phase 3 |
| Completed | Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients NCT01436747 | University Medical Centre Ljubljana | Phase 3 |
| Completed | NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria NCT01547897 | TME Pharma AG | Phase 2 |
| Unknown | Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients NCT01316068 | Sun Yat-sen University | Phase 4 |
| Completed | Correlation of Albuminuria With Arterial Stiffness NCT01041599 | Istanbul University | — |
| Terminated | Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients NCT00961207 | Cook County Health | Phase 4 |
| Completed | Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria NCT00625820 | University of Michigan | Phase 2 |
| Completed | Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation NCT01564966 | Istanbul University | — |
| Completed | Evaluation of Albuminuria HIV-Infected Patients NCT00524992 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS NCT01071785 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria NCT01375322 | TSH Biopharm Corporation Limited | Phase 4 |
| Terminated | Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes NCT00208221 | Institut de Recherches Cliniques de Montreal | Phase 3 |
| Completed | Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy NCT00312780 | Symphony Evolution, Inc. | Phase 2 |
| Unknown | Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes NCT00263419 | Heidelberg University | N/A |
| Completed | Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria NCT00095290 | Bristol-Myers Squibb | Phase 4 |
| Unknown | Rationale and Design for Shiga Microalbuminuria Reduction Trial NCT00202618 | Shiga University | Phase 4 |
| Completed | Aldosterone and Vascular Disease in Diabetes Mellitus NCT00214825 | Brigham and Women's Hospital | N/A |
| Completed | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus NCT00136773 | Novartis | Phase 4 |
| Recruiting | Family Investigation of Nephropathy and Diabetes (F.I.N.D.) NCT00342927 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |